ethyl methacrylate-co-ethylene glycol dimethacry late] (PDE) thin films were synthesized via initiated chemical vapor deposition (iCVD) and reacted with 1,3-propane sultone to obtain the zwitterionic structure. The cross-linker ethylene glycol dimethacrylate (EGDMA) was utilized to make the copolymer insoluble in water. The composition of the copolymer was tuned by varying the flow rates of precursors and calculated from Fourier transform infrared spectroscopy (FTIR) spectra. The zwitterionic coatings were covalently grafted on to reverse osmosis (RO) membranes, and surface characterizations were carried out. Scanning electron microscope (SEM) and atomic force microscope (AFM) revealed that the iCVD zwitterionic coatings were conformal and smooth over the RO membrane, and the coating thickness can be measured by using ellipsometry. Salt rejection was not impaired by the coating. Permeation tests were carried out under different feed pressures, film thicknesses, and film compositions, showing a 15% to 43% reduction in permeation. Cell adhesion tests were carried out using Escherichia coli, and the coated RO membranes showed superior antifouling performance compared with the bare RO membrane. This is the first time that the library of iCVD functional groups has been extended to charged zwitterionic moieties, and the zwitterionic coatings have been applied on delicate substrates, such as RO membranes.

N,N-Dodecyl,methyl-polyethylenimine coatings applied to solid surfaces have been shown by us to disinfect aqueous solutions of influenza viruses. Herein we elucidate the mechanism of this phenomenon. Infectivity-, protein-, RNA-, and scanning electron microscopy-based experiments reveal that, upon contact with the hydrophobic polycationic coating, influenza viruses (including pathogenic human and avian, both wild-type and drug-resistant, strains) irreversibly adhere to it, followed by structural damage and inactivation; subsequently, viral RNA is released into solution, while proteins remain adsorbed.antiviral | biocide | virucidal coating

No abstract

Here we present a new bifunctional layer-by-layer (LbL) construct made by combining a permanent microbicidal polyelectrolyte multilayered (PEM) base film with a hydrolytically degradable PEM top film that offers controlled and localized delivery of therapeutics. Two degradable film architectures are presented: 1) bolus release of an antibiotic (gentamicin) to eradicate initial infection at the implant site, or 2) sustained delivery of an anti-inflammatory drug (diclofenac) to cope with inflammation at the site of implantation due to tissue injury. Each degradable film was built on top of a permanent base film that imparts the implantable device surface with microbicidal functionality that prevents the formation of biofilms. Controlled-delivery of gentamicin was demonstrated over hours and diclofenac over days. Both drugs retained their efficacy upon release. The permanent microbicidal base film was biocompatible with A549 epithelial cancer cells and MC3T3-E1 osteoprogenitor cells, while also preventing bacteria attachment from turbid media for the entire duration of the two weeks studied. The microbicidal base film retains its functionality after the biodegradable films have completely degraded. The versatility of these PEM films and their ability to prevent biofilm formation make them attractive as coatings for implantable devices.